Therapy (MDR-TB)

Surgery Plays Important Ancillary Role in Resistant TB

Published in TB and Outbreaks Week, July 7th, 1997

Surgery plays an important ancillary role in the treatment of certain drug-resistant strains of Mycobacterium tuberculosis, according to a report from South Africa.

Researcher Marc Van Leuven and colleagues found that pulmonary resection can be performed safely and routinely in specialized units with acceptable levels of morbidity and mortality ("Pulmonary Resection as an Adjunct in the Treatment of Multiple Drug-Resistant Tuberculosis," The Annals of Thoracic Surgery," May 1997;63(5):1368-1373).

The incidence of pulmonary disease due to drug resistant M. tuberculosis (MDR-TB) has increased worldwide in recent years.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1997-07-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry